Promega Corporation

2800 Woods Hollow Road
Madison, WI 53711
460 Employees

SBIR Award Summary

Total Number of Awards 29
Total Value of Awards $2.77MM
First Award Date 01/01/91
Most Recent Award Date 06/11/99

Key Personnel

Last Name Name Awards Contact
Zdanovsky Dr. Alexey G. Zdanovsky 3
Wood Keith Wood 3
Riss Terry L Riss 1
Golumbeski George S Golumbeski 1
Wood Keith V Wood 4
Schaefer Erik M Schaefer 1
Schumm James W Schumm 3
Shultz John W Shultz 2
Zdanovsky Alexey G Zdanovsky 2
Lesley Scott Allan Lesley 1
Haak-Frendscho Mary Haak-Frendscho 1
Bacher Jeffery Walter Bacher 3
Lowery Dr. Robery Lowery 2
Knuth Dr. Mark W. Knuth 2
Grosch Dr. Josephine C. Grosch 2

29 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/11/99 - 10/30/01

We propose the development of an efficient, non-invasive, automated approach for detection of genomic instability which occurs during the growth of cancerous tissues. This diagnostic assay will identify tumor DNA present in peripheral body fluids such as blood, sputum, urine, or stool. The proposal exploits t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/98 - 05/31/99

We propose the development of an efficient, non-invasive, automated approach for detection of genomic instability which occurs during the growth of cancerous tissues. This diagnostic assay will identify tumor DNA present in peripheral body fluids such as blood, sputum, urine, or stool. The proposal exploits t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/98 - 05/31/99

Early, definition detection of pathogenic agents often is key to effective treatment and full recovery. Although DNA and protein-based detection systems are widely used to detect pathogen and disease markers, a number of systems have limited capacity to rapidly produce reagents specific for e...

Phase 2 SBIR

Agency: Army
Topic: A96-138
Budget: 03/02/98 - 03/02/00

This Phase II proposal is designed to continue a unique interdisciplinary research involving a team that has at its disposal all skills and talents to design, synthesize and test novel organic structures that inhibit all or several of the known BoNT-metalloproteases. Innovations in combinatorial chemistry applied to structural leads discovered...

Phase 1 SBIR

Agency: Army
Topic: A97-112
Budget: 11/14/97 - 05/13/98

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 09/30/98

The project will examine the potential of producing an extremely sensitive DNA measurement system based upon the transformation of the nucleotides in DNA to mononucleotide triphosphates followed by detection of the triphosphates using Luciferase. Two different strategies will be explored for the formation of nu...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 05/31/98

We propose the development of an efficient, non-invasive, automated approach for detection of genomic instability which occurs during the growth of cancerous tissues. This diagnostic assay will identify tumor DNA present in peripheral body fluids such as blood, sputum, urine, or stool. The proposal exploits t...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/97 - 07/31/98

In the drug discovery process, there is increased need for greater throughput screening for lead compounds at reduced cost. Concomitant with this is a greater use of living cells in screening assays to yield more accurate information on biological efficacy. We propose a new techno...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/97 - 10/31/98

The continuing development and use of polymorphic DNA markers has become an increasingly effective means of identifying genetic traits or individuals. Improvements in speed and sensitivity of this technology have produced growing commercial opportunities for applications in linkage analysis, disease detec...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/97 - 05/30/98

DESCRIPTION: (Adapted from the applicant's abstract) This proposal describes strategies to synthesize potent non-competitive inhibitors of botulinum neurotoxin metalloproteases {BoNT protease}. These metalloproteases which are the molecular effectors of the paralytic effects of these toxins...

Load More